Background: The present survey was undertaken to gain insights in the changes of disease management of multiple myeloma (MM) over time and the implementation of new guidelines into daily practice. Patients and Methods: Diagnosis and treatment of MM were evaluated based on a 3-month representative...
Clinical experience with advanced imaging techniques in the management of multiple myeloma (MM) has sufficiently progressed to the point that they are now recommended for expanded use outside of the clinical trial setting for the diagnosis of MM requiring treatment, as well as to assess response ...
A myeloma diagnosis can be devastating, it is important to remember that there are several promising new therapies. The estimated frequency of multiple myeloma is 5 to 7 new cases per 100,000 persons per year. Multiple myeloma is characterized by excessive numbers of abnormal plasma cells in the...
Survival of multiple myeloma (MM) has significantly improved over the last decade; however, a composed group of patients (15-20%), named high-risk (HR) MM, still experience reduced survival. Both tumor biology and suboptimal/absent responses to therapy may underlie HR definition and a clear ...
For clinical diagnosis, the situation is very complicated and there are many incentives. However, there is a kit for testing in the experiment, which is easy to operate and has clear results. It can quickly determine the free calcium concentration in plasma, and then perform correlation by dete...
Multiple myeloma is a disease typical of elderly people, with a median age at diagnosis of 70 years. Much progress has been made in the past few years than... Alessandra,Larocca,Antonio,... - 《Blood》 被引量: 36发表: 2015年 How I treat high-risk myeloma The treatment of patients wi...
Multiple myeloma is discovered through routine blood screening when patients are being evaluated for other problems such as frequent infections. Since 2000, the percentage of patients living five years after diagnosis has been on the rise. With improved treatment, survival results are likely to be ...
The patient was given a diagnosis of multiple myeloma with high-risk cytogenetics. Targeted Oncology:What are the treatment options for this patient? Ailawadhi:This a 77-year-old high-risk patient with good performance status. He has anemia and some kidney disfunction and hypercalcemia. ...
to be diagnosed with MM, and they are typically younger at disease onset, even though MM is usually most prevalent in patients ages 65 and up.7This leads to further disparities, as Black patients — along with members of the Hispanic community — often face delayed diagnosis and tend ...
Poster 471 How a Liver Function Test Led to the Diagnosis of Multiple Myeloma in a Stroke Patient: A Case ReportDisclosures M. Tahani, none. Patients or Programs A 71-year-old woman with ischemic CVA. Program Description She presented to the emergency department after a week of confusion, ...